BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 35269467)

  • 1. Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States-Current View of Knowledge.
    Lipke K; Kubis-Kubiak A; Piwowar A
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity.
    Bansal SK; Bansal MB
    Aliment Pharmacol Ther; 2024 Jun; 59 Suppl 1():S10-S22. PubMed ID: 38451123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle.
    Tumova J; Andel M; Trnka J
    Physiol Res; 2016 Jun; 65(2):193-207. PubMed ID: 26447514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle.
    Ye J
    Endocr Metab Immune Disord Drug Targets; 2007 Mar; 7(1):65-74. PubMed ID: 17346204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
    Cusi K
    Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver.
    Boden G
    Curr Diab Rep; 2006 Jun; 6(3):177-81. PubMed ID: 16898568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free fatty acids and skeletal muscle insulin resistance.
    Rachek LI
    Prog Mol Biol Transl Sci; 2014; 121():267-92. PubMed ID: 24373240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
    Ziegler O; Quilliot D; Guerci B; Drouin P
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):261-70. PubMed ID: 11452220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.
    Boden G; Shulman GI
    Eur J Clin Invest; 2002 Jun; 32 Suppl 3():14-23. PubMed ID: 12028371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle.
    Park SS; Seo YK
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.
    Martins AR; Nachbar RT; Gorjao R; Vinolo MA; Festuccia WT; Lambertucci RH; Cury-Boaventura MF; Silveira LR; Curi R; Hirabara SM
    Lipids Health Dis; 2012 Feb; 11():30. PubMed ID: 22360800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent effects of fatty acids on skeletal muscle metabolism.
    Hirabara SM; Silveira LR; Abdulkader F; Carvalho CR; Procopio J; Curi R
    J Cell Physiol; 2007 Jan; 210(1):7-15. PubMed ID: 17013887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting fatty acid metabolism to improve glucose metabolism.
    Stinkens R; Goossens GH; Jocken JW; Blaak EE
    Obes Rev; 2015 Sep; 16(9):715-57. PubMed ID: 26179344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
    Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional fat cells, lipotoxicity and type 2 diabetes.
    DeFronzo RA
    Int J Clin Pract Suppl; 2004 Oct; (143):9-21. PubMed ID: 16035392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free fatty acids and pathogenesis of type 2 diabetes mellitus.
    Bergman RN; Ader M
    Trends Endocrinol Metab; 2000 Nov; 11(9):351-6. PubMed ID: 11042464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic syndrome and lipotoxicity].
    Shimabukuro M
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1721-5. PubMed ID: 17037305
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.
    Liang H; Tantiwong P; Sriwijitkamol A; Shanmugasundaram K; Mohan S; Espinoza S; Defronzo RA; Dubé JJ; Musi N
    J Physiol; 2013 Jun; 591(11):2897-909. PubMed ID: 23529132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free fatty acids: mediators of insulin resistance and atherosclerosis].
    Castro Cabezas M; Erkelens DW; van Dijk H
    Ned Tijdschr Geneeskd; 2002 Jan; 146(3):103-9. PubMed ID: 11826668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.